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Abstract 
Increasing 2-dose vaccination coverage has led to an interruption of endemic measles virus circulation 
in Germany. However, outbreaks after virus importation still occur and contribute to international 
transmission chains. Between 2003 and 2009, annual measles incidence ranged between 0.2 and 2.8 
per 100,000 population. Immunization gaps have been identified especially in secondary-school 
students and young adults, which is also reflected by a shift in age distribution of reported measles 
cases toward older age groups. Stronger political commitment and standardized guidelines for 
outbreak containment were put in place in Germany in the past years, but the last step toward 
measles elimination cannot be made until the number of susceptible individuals has been further 
reduced. In addition to routine childhood vaccination, supplementary immunization activities are 
needed targeting school students and young adults to close critical immunization gaps. Intensification 
of public awareness and sound information on vaccinations are necessary to convince skeptics and 
remind the forgetful.  
Germany committed itself to attain the World Health Organization (WHO) goal of measles elimination 
in the European region and implemented a national intervention program against measles, mumps 
and rubella (MMR) in 1999 [1]. As of 2010, WHO performance indicators for measles surveillance [2] 
were mainly achieved, and Germany has experienced a declining trend in measles activity during 
recent years. However, elimination targets have not been fully reached in Germany yet: Regionally 
limited outbreaks occurred almost every year and contributed to long-lasting transmission chains in 
Europe [3], and 95% vaccination coverage with 2 doses of measles-containing vaccine (MCV) has not 
been reached in children.  
Germany consists of 16 federal states with a total of ∼82 million inhabitants. Measures for disease 
control, including implementation of vaccination recommendations and activities and monitoring of 
vaccination coverage, is the responsibility of the individual states. The German Standing Committee 
on Vaccination (STIKO) provides recommendations, which are endorsed by the state health 
authorities. Vaccinations are not obligatory and also not required for attending public schools, 
kindergartens, or the like. General practitioners and pediatricians usually administer the vaccines, 
  
which are financed by the statutory health insurance system. There are substantial regional 
differences in population densities and in various aspects of health care. In particular with regard to 
vaccination coverage, differences still exist between states that belonged to West Germany before 
reunification in 1990 (old federal states [OFSs]) and those that belonged to the German Democratic 
Republic (new federal states [NFSs]) [4, 5]. Our objective was to characterize the measles 
epidemiology in Germany by describing the surveillance infrastructure and epidemiologic trends and 
by highlighting some examples of special measures that state health authorities have initiated together 
with federal public health institutions to accelerate measles elimination in Germany.  
 
Measles epidemiology 
Since 2001, both clinically suspected and laboratory confirmed measles cases have to be reported to 
local health departments in Germany according to the Communicable Diseases Law Reform Act 
(IfSG). The local health departments are in charge of conducting control measures and electronically 
report cases via the state health department to the Robert Koch Institute (RKI), the federal institution 
for disease prevention and control [6]. The WHO performance indicators for measles surveillance in 
terms of timeliness and completeness of reporting and adequacy of investigation are achieved by the 
system [2]. At least 90% of case reports have complete information on age, sex, date of disease 
onset, vaccination status, date of last vaccination, and travel history. Underreporting of measles cases 
by the national surveillance system is likely, but its degree is unknown. Between 2007 and 2009, 
∼80% of reported measles cases without epidemiologic link were laboratory confirmed, either 
serologically or with polymerase chain reaction.  
An annual incidence of <0.1 cases per 100,000 population, 80% of outbreaks with <10 cases, and no 
endemic circulation of imported measles virus (MV) strains for >12 months are WHO indicators and 
targets for measles elimination [2]. Whereas annual incidences were >5 cases per 100,000 population 
in 2001 and 2002 in Germany, this number dropped to 1 per 100,000 since 2003 with 2 exceptions: 
first in 2004, when the lowest measles incidence was reached with (0.2/100,000) and second in 2006, 
when a large outbreak with 1749 reported cases occurred in North–Rhine Westphalia, belonging to 
the OFS, increasing the national incidence to 2.8/100,000. Annual incidences in the 16 federal states 
varied considerably (0–18/100,000) and were on average lower in the NFSs (mean incidence 2003–
2009, .14/100,000) than in the OFSs (1.22/100,000) (Table 1). The largest outbreak observed in the 
NFSs since 2001 included only 14 cases. In the OFSs, outbreaks with >20 cases have occurred every 
year, but the size and duration of these outbreaks have decreased during the past 9 years (Figure 1).  
As in other countries in the preelimination phase, an increasing proportion of cases in older age 
groups and an increase in age-specific incidences in persons 10–39 years of age have been observed 
in Germany since 2006 (Figure 2). Whereas the incidence generally decreased among children <10 
years of age, it remained high in infants (incidence range in infants, 2.1–5.7/100,000 in 2003–2005 vs 
3.5–7.3/100,000 in 2007–2009).  
 
Molecular epidemiology 
Genetic characterization of circulating MV has been established at the National Reference Centre for 
Measles, Mumps, and Rubella (NRC-MMR) at the RKI in the mid-1990s. The indigenous European 
genotypes C2 and D6 (MVi/Kempten.DEU/23.00, MVi/Berlin.DEU/47.00) were predominant in 
Germany until 2000 and then rapidly replaced by D7 (MVi/Mainz.DEU/06.00) from 2000 to 2002 [7]. 
Transmission of indigenous MV variants was tapering off in 2003, and has been interrupted in 2004 
[8]. A variety of MV strains was detected from 2005 onward (Table 2). Most of them were identical to 
MV circulating in other European countries or endemic in Asia and Africa, indicating that all of these 
viruses were imported. They led to limited outbreaks in Germany and contributed to international  
In 2006, the above mentioned outbreak in North Rhine–Westphalia was caused by a MV genotype D6 
(MVs/Moenchengladbach.DEU/19.06), which was unrelated to the D6 virus detected in a Bavarian 
outbreak in 2005, but showed identity to the D6 virus (MVs/Kyiv.UKR/03.06/1) causing a large 
outbreak in the Ukraine in 2005–2006. Therefore, importation from Eastern Europe was likely.  
  
The MV variant D5-Lucerne was observed in Lower Bavaria in 2007 and a year later in Upper Bavaria, 
Baden-Wuerttemberg, and in smaller outbreaks all over Germany (Table 2) [15], probably owing to 
multiple importations from Switzerland, where a large outbreak was observed from 2006 to 2009 
(>4400 cases) [14]. D5 transmission was no longer detected in Germany in 2009, when various D4 
variants were found instead, closely related to D4-Enfield; an imported D4 variant from the United 
Kingdom was associated with an outbreak in Hamburg and Lower Saxony (Table 2) and was 
subsequently exported to Bulgaria, where it started to circulate mainly within the Roma community 
[17]. In 2009, a second D4 variant was detected in North Rhine–Westphalia and a third D4 strain in 
Baden-Wurttemberg (Table 2), suggesting multiple importations from outside the country rather than 
spread within Germany.  
Although MV genotypes and variants such as D4-Enfield and D5-Lucerne did not become endemic in 
Germany, it is evident that endemic transmission of these viruses did occur in the WHO-EURO zone 
[Mankertz et al, in this issue]. Molecular surveillance supports the fact that endemic MV circulation has 
been interrupted in Germany since 2003, but the number of susceptible individuals is still large enough 
to allow measles outbreaks to occur after virus importation.  
 
Measles vaccination coverage 
Childhood measles vaccination with 1 vaccine dose was recommended in the OFSs since 1973, with 
voluntary application, and it was mandatory for school and kindergarten entry in the NFSs since 1970 
with 1 vaccine dose and since 1986 with 2 vaccine doses, until reunification in 1990. After reunification 
of Germany in 1991, the STIKO recommended a 2-dose MCV schedule, with the first dose 
administered to children 1 year of age and the second to 4–6-year-olds. In 2001, the recommended 
ages for the first and second doses were changed to 11–14 months and 15–23 months, respectively, 
to provide an early second chance to gain immunity.  
Vaccination coverage in Germany is routinely assessed at school entry, normally at the age of 6 years, 
and has increased in recent years (Figure 3). The increase in vaccine uptake was most prominent for 
the second vaccine dose in 2001–2005, which correlated with the above-described change in the 
target age group. For children entering school in 2008, coverage with 1 MCV dose was 96%. Two-
dose coverage was 89%, still below the critical 95% coverage recommended for elimination [2, 19]. 
Coverage was lower in the OFSs than in the NFSs (1 dose, 95.6% vs 97.8%; 2doses 88.6% vs 
92.1%). The regional differences in coverage are likely to be a consequence of historically formed 
attitudes toward vaccination, and differences in engagement of the local public health service with 
regard to supplementary immunization activities (SIAs) in the different states. The denominator for 
calculating vaccination coverage is based on the number of students presenting their vaccination 
records at the medical school entry examination (∼90%). The true coverage is therefore likely to be 
lower than presented above, assuming that those students who present their records are more likely to 
be vaccinated [11].  
Outbreak investigations revealed that the main reasons for not being immunized were lack of 
awareness or rejection because of the perception of measles as a mild disease, the fear of vaccine-
related adverse events, and false understanding of contraindications [12, 16]. Besides better 
information and increased public awareness about measles and the benefits of vaccination, reminder 
and recall systems would be beneficial to both physicians and patients, to check and close 
immunization gaps whenever possible [20].  
Philosophical beliefs in Germany and German -speaking areas of other European countries are 
associated with limited compliance with existing vaccination recommendations [21]. Several large-
scale outbreaks occurred in recent years in private anthroposophic kindergartens or schools, where 
coverage is usually low [15, 18]. Anthroposophic physicians do not oppose immunization in general, 
but they prefer vaccinations based on an individual indication and at older age than recommended as 
they believe it might be favorable for a child's development to undergo natural infection [22, 23]. 
According to data from the representative German Health Interview and Examination Survey for 
Children and Adolescents (KIGGS) in 2003–2006, measles vaccination coverage was especially low in 
children with parents reporting general reservations against vaccinations, and also in foreign-born 
migrants, who had a 3-fold increased odd of being unvaccinated [24]. Unfortunately, data on health 
behavior or vaccination coverage in migrants or ethnic minorities are rare in Germany. The fact that 
  
outbreaks started in unvaccinated persons of ethnic minorities in Hessen in 2004 and Hamburg in 
2009 (local health department, personal communication) demonstrated that more attention must be 
paid to persons who otherwise would not seek health prevention measures on their own.  
 
A state vaccination campaign 2007–2008 
In the biggest outbreak in recent years, >1700 measles cases were recorded in North Rhine–
Westphalia in 2006, most of them unvaccinated students 9–18 years of age. Because data on 
vaccination coverage exist only from school entry examinations, little was known about the vaccination 
status of children >6 years. But according to data from the above mentioned KIGGS, the average 2-
dose MCV vaccination coverage was 77.5% among children aged 14–17 years. In the light of these 
survey results and the 2006outbreak, the North Rhine–Westphalia State Ministry of Labor, Health and 
Social Affairs decided to carry out a vaccination campaign in 2007, involving all 54 local health 
departments and various other partners. Its purpose was to identify and close immunization gaps by 
offering voluntary vaccination at schools. However, not all local health departments contributed to this 
SIA, owing to varying levels of staffing and organization. The state vaccination campaign took place 
from November 2007 to June 2008 and focused on students 10–21 years of age. Participating local 
health departments received a set of information materials and financial support for the 
implementation of the campaign. The state ministry established email and telephone hotlines for 
professional health staff and the public. Local health departments checked the vaccination records 
and vaccinated children at schools either by themselves or with support of the Regional Association of 
Physicians, complementary to the usual vaccination through family physicians. The status of MMR 
vaccinations, and other vaccinations if possible, was recorded anonymously.  
Of the 54 state municipalities, 51 participated in the SIA. According to the state school list, 2.8 million 
students attended secondary schools in 2008. The evaluation included 264,634 persons aged 10–21 
years with complete data sets submitted by 51 municipalities; this corresponded to 9.4% of all 
students of that age group in the state. Of the 264,634 school students analyzed, 247,439 (93.5%) 
had received ≥1 MCV dose, and 17,195 (6%) were unvaccinated. Vaccination coverage with 2 MCV 
doses varied from 26.9% to 91.0% by municipality, with an average of 80.3%. The percentage of 
students that had not received any vaccination against measles ranged from .3% to 28.9% per 
municipality. No difference was found between male and female students. The vaccination status was 
best for the youngest age group (88%) and dropped significantly with increasing age to 56% at 21 
years (for 2 MCV doses, P < .05) (Table 3). In total, almost 8000 MMR vaccine doses were 
administered at schools during the SIA, covering around 3% of the target group. Parents of children 
with incomplete vaccination status often preferred to have the vaccination done by their family 
physician or pediatrician, which was the case for ∼60% of students for whom vaccinations were 
recommended during the campaign but not completed at school.  
For the first time in recent years, a state-wide vaccination campaign was conducted by a federal state 
in Germany and assessed measles vaccination coverage in students 10–21 years of age. The 
campaign made a major contribution to improving the vaccination situation in North Rhine–Westphalia, 
although it did not meet the target. It clearly confirmed that older students especially have 
considerable deficits in their vaccination status. It also showed that students at specific types of 
schools (vocational schools, extended elementary schools) benefit most when vaccinations are offered 
at school, because the lowest vaccination coverage was found in these populations. The results show 
clearly that immunization of older adolescents and young adults is urgently warranted. At many 
schools, only a small proportion of students submitted their vaccination record, and it can be assumed 
that the vaccination status of students without vaccination records is even worse. In future SIAs, 
persons who not present their records should receive the same offers and reminders as the 
unvaccinated. The vaccination campaign of 2007–2008 showed that closing immunization gaps is 
most effective if offering information and vaccination services in schools. However, these school-
based programs must be prepared and accompanied by targeted information campaigns to improve 
parents' attitudes toward such activities. Because of the observed age shift in measles cases and 
detected immunization gaps in young adults, STIKO decided in 2010 to recommend measles 




Measles case management 
Based on the If SG, local health departments may forbid persons with suspected or confirmed 
measles or their susceptible household contacts to attend or work in community facilities, such as 
schools or kindergartens. The large 2006 outbreak in North Rhine–Westphalia led to a debate in 
Germany on how to manage measles cases, especially among school students which has resulted in 
special guidelines for the public health service in the federal state of Lower Saxony [25]. Local health 
departments are technically supported in their measles control by the Governmental Institute of Public 
Health of Lower Saxony, which in turn cooperates with RKI and the NRC-MMR. The guidelines consist 
of 5 key elements:  
1. Intensive follow-up of the index case: The most important element is a consistent early 
intervention at the occurrence of the first measles case to contain the spread of infection. This 
includes the search for the source of infection and the investigation of contact persons 
including their vaccination status and attendance at community facilities.  
2. Laboratory confirmation of diagnosis: For reliable surveillance, ≥80% of measles cases should 
be confirmed by laboratory diagnostics [2]. Confirmation of the diagnosis is also important for 
other measures of case management, such as isolation. Local health departments initiate and 
finance laboratory investigations if adequate testing was not already initiated by the consulted 
physician.  
3. Dissemination of information: Patients, their household members, staff and attendees of 
community facilities, physicians, laboratories, hospitals, and the media are being informed 
about the existing legal obligations and the purpose of the measures. Information material and 
letter templates are attached to the guidelines to ensure consistent and easily available 
information.  
4. Vaccination: It is necessary to clarify whether susceptible individuals were in close contact 
with the case and whether postexposure vaccination is still an option. If so, the public health 
service of Lower Saxony will verify the actual vaccination status and actively offer 
vaccinations.  
5. Isolation: Persons with suspected or confirmed measles, as well as their unprotected contacts 
are prohibited from attending or working in community facilities. Persons are regarded as 
unprotected as long as they cannot prove that they were vaccinated (children usually with 2 
doses, adults with ≥1 dose of MCV) or had measles previously. In the case of a vaccination 
within the first 3 days of exposure, isolation can be abandoned. The legal scope of the IfSG 
allowing such measures is specified in the guidelines but will need to be applied to only a few 
persons when vaccination coverage is high in the population.  
Since the implementation of the guidelines in 2007, measles outbreaks were successfully limited and 
mitigated in Lower Saxony [26]. Nevertheless, MV infections still occurred, especially in certain 
population subgroups. The relatively high number of cases in 2009 was due to a supraregional 
outbreak in the federal state of Hamburg, adjoining Lower Saxony. Of the 72 cases reported 2009 in 
Lower Saxony, 43 were epidemiologically linked to cases in Hamburg. However, no secondary case 
arose from these cases in Lower Saxony. Intensified surveillance, according to the guidelines of the 
WHO, as well as consistent case management, as proposed in the Lower Saxon Guidelines, proved 
useful in preventing secondary cases after MV importation and spread to highly vulnerable 
populations.  
 
National Immunization Conference 
As demanded by the resolution from the first “Meeting of German-speaking Countries and Areas on 
Measles and Rubella Elimination,” which was held with WHO/Europe in Berlin in May 2006, political 
commitment has changed over time [21, 27]. On the initiative of the federal state of Rhineland-
Palatinate the 16 German state health ministers have decided to hold National Immunization 
Conferences (NICs) every 2 years. Elimination of measles was a main topic of interest at the first 3-
day-long NIC in Mainz in March 2009. Some key recommendations to combat measles and to improve 
vaccination coverage emerged from presentations given by experts from the federal states, as well as 
from numerous posters and abstracts presented. Subsequent to the NIC, an overview of these 
recommendations was included in a “good practice manual,” which will be published online and can be 
  
used as a support for public health authorities to eliminate measles. The recommendations are as 
follows:  
1. Public health service activities: Public health services activities should focus mainly on 
schools, and include checking vaccination records combined either with vaccination on site or 
recommendations to obtain any missing vaccinations.  
2. Recall systems in connection with school entry examination: The established activity for 
checking vaccination status at school entry was used in one federal state for the 
implementation of a recall system which showed promising results in closing immunization 
gaps.  
3. Measles management with public health action plans: Detailed action plans were implemented 
in Lower Saxony (as described above) and in Bavaria. Key elements include the use of 
surveillance instruments and standardized procedures for the management of individual cases 
and outbreaks.  
4. Public awareness campaigns: The general public needs to be reminded of the need for 
vaccinations by the provision of scientifically sound information. It is necessary to work against 
the uncertainty and confusion of parents and physicians in the field of vaccinations and 
particularly to counterbalance misinformation by aggressive antivaccination groups. Motivation 
tools could include cinema advertisements and campaigns using a variety of posters and 
flyers. Information materials should address the general public but also specific target groups.  
5. Monitoring vaccination coverage: Monitoring coverage is crucial for improving immunization 
strategies. A new monitoring method in Germany uses billing data from the Association of 
Statutory Health Insurance Physicians. If this system can provide representative estimates, it 
could be an effective tool to collect vaccination coverage data across all age groups [28].  
One important reason for the development of immunization gaps is the skepticism and lack of 
information among parts of the population. Alongside very small groups of steadfast vaccination 
opponents, who will not be swayed by reasonable arguments, there is a critical attitude toward 
vaccines in substantial parts of the medical community, particularly among those favoring 
anthroposophic medicine. Because these voices have a significant influence on parental opinion, 
dialogue was sought with these groups at the first NIC. Supported by intensive discussions in the 
years before, an influential group of anthroposophic doctors changed their point of view and 
announced on the conference that they will now be recommending measles vaccination [22].  
Another important finding of the first NIC was that there are fundamentally good vaccination programs 
in Germany, but there are several responsible parties and decision makers, whose work is still not 
properly coordinated. As a result of the NIC, federal states decided on a national immunization plan 
that specifically incorporates the WHO target of measles elimination.  
 
Conclusion 
Disease and molecular surveillance data demonstrate that endemic MV circulation halted in Germany 
in 2003, but imported viruses continued to cause outbreaks with limited spread and duration especially 
in the western part of the country where vaccination coverage is lower. These outbreaks have 
contributed to sustained transmission chains in Europe. Lack of knowledge, poor acceptance of 
measles vaccination for philosophical reasons, and neglect are the main reasons for not being 
vaccinated in Germany. Successful measles elimination strategies have to include additional efforts to 
address these challenges and to overcome all possible obstacles to close immunization gaps.  
Ministries of health at state and federal level have taken a number of measures to achieve measles 
elimination in Germany, which include state-wide SIAs with focus on schools, the introduction of 
measles management guidelines for local health authorities, the development of a national 
immunization plan, and the implementation of biyearly NICs. School-based SIAs should be conducted 
in all federal states. The extension of STIKO recommendation on measles vaccination to adults is 
aiming to close immunization gaps. Measles elimination has to be defined as a high-priority public 
health goal that needs stronger political commitment and coordinated measures by state, federal, and 
local authorities. The next NIC, scheduled to take place in February 2011 in Baden-Wurttemberg, will 
provide an opportunity to assess the progress and to exchange experiences with successful concepts 
working toward the goal of measles elimination in Germany and Europe.  
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 Table 2. Major Measles Outbreaks in Germany Since 2005 With Dominant Measles Virus Genotype 






Number of cases by year and federal state according to electronic reporting system; the 
number may differ from the actual number of cases involved in the outbreak, because not all reported 
cases are genotyped or epidemiologically linked and genotype results are not always linked to 
reported case. MV, measles virus. 
* All isolated viruses as indicated in the Measles Nucleotide surveillance database (MeaNS); available 
at http://www.who-measles.org/Public/Web_Front/about_db.php; accessed 7 March 2011. 
  
Table 3. Vaccination Status for Measles-Containing Vaccine (MCV) by Age in Participants of the State 
Vaccination Campaign, North Rhine–Westphalia, Germany, 2007–2008  
 
  
Figure 1. Number of measles cases by quarter and federal states with highest incidences 
(cases/100,000 population) in the respective years due to outbreaks in Germany, 2001–2010. Roman 
numerals with years indicate quarters. BE, Berlin; BW, Baden-Wurttemberg; BY, Bavaria; HB, 
Bremen; HE, Hessen; HH, Hamburg; NI, Lower Saxony; NW, North Rhine–Westphalia; RP, 






























Figure 3. Coverage with 1 or 2 doses of measles vaccine in old and new federal states (OFS and 
NFS) of Germany, assessed at school entry examination (at 4–6 years of age) in 1998–2008.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
